All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 7 read as filed from the record and 2 are SI estimates, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
1 warning event since 2017; the latest 2021-04-30.
From the record
Concord Medical Services Holding Limited's filings since 2017 show 1 warning event: a late-report notice (Form NT 10-K or NT 10-Q, the latest 2021-04-30) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
+0.1% a year over 10 filed years; profitable in 0 of 10.
From the record
Concord Medical Services Holding Limited's 10 filed years say what it did: revenue went from CNY 455 million in fiscal 2016 to CNY 461 million in fiscal 2025, up 0.1% a year; it rose in 5 of 9 years; the deepest fall was 58% from fiscal 2016 to fiscal 2018; net income was positive in 0 of 10 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
SI estimate 9.4/10, confidence 35 of 100 (one part).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Concord Medical Services Holding Limited's shareholder treatment is put at 9.4 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the top 6% of 9 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.
What are they doing right now?
Is it financially healthy right now?
ROE -5%: lost 5¢ per shareholder dollar. Leverage 72%: owes 72¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2025-12-31, Concord Medical Services Holding Limited lost about 5 cents for every dollar of shareholders' money, and gross profitability: its products earned about 0 cents per dollar of everything the company owns. Leverage: it owed about 72 cents per dollar of assets, and net share issuance: its share count was unchanged over the year (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
bottom 22% of 9 in its family; net margin -20.2%.
From the record
Concord Medical Services Holding Limited's standing among 9 graded names in its industry family: revenue of CNY 461 million in fiscal 2025 is not ranked by size, since the family reports in another currency; a net margin of -20.2% ranks in the bottom 17%; revenue growth of -0.8% a year over the last 3 filed years ranks in the bottom 28% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
SI estimate 6.7/10, confidence 20 of 100 (family median).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Concord Medical Services Holding Limited's leadership is put at 6.7 of 10 with a confidence of 20 of 100, because it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-03-18 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 8 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 6 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.
What are they set up to do next?
How much room does it have to grow?
bottom 11% of 9 in its family for room to expand.
From the record
Concord Medical Services Holding Limited's room to grow, from the newest filed statements (fiscal 2025): cash of CNY 299 million against debt of CNY 2.5 billion leaves -33.1% of its assets as net cash, bottom 17% of its family; cash from operations less capital spending is -56.1% of revenue (bottom 6%); a gross margin of 5.6% (bottom 10%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
bottom 48% of 8 in its family for growth drivers.
From the record
Concord Medical Services Holding Limited's growth drivers, from the filed years to fiscal 2025: revenue grew -0.8% a year over the last three filed years against 0.1% over all 10, slowing (top 44% of its family); the newest year grew 20% (top 44%); capital spending grew -36.8% a year (bottom 31%) (its annual reports). Concord Medical Services Holding Limited reported 2 lines of business in fiscal 2025: Hospital at CNY 374 million (81%), Network at CNY 87 million (19%); 1 of 2 grew against the year before (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
top 31% of 6 in its family for expectations against reality.
From the record
Concord Medical Services Holding Limited's newest year against its own record: revenue of CNY 461 million in fiscal 2025 came in 33% above the CNY 346 million its prior three years' pace pointed to (top 8% of its family); net income of CNY 93 million against a prior three-year average of CNY 365 million (bottom 42%); a net margin of -20.2% against -79.8% before (top 25%) (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made